Partner Content Partner Content Program to Discuss eRegulatory Submission Processes and Prot... Summit will explore the electronic submission process and protocols for IDMP, RIM, global, and regulatory submissions.
News Click claims FDA okay for first-in-class schizophrenia DTx Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
